Immunovia AB (OSTO:IMMNOV)
kr 0.618 -0.01 (-1.59%) Market Cap: 104.88 Mil Enterprise Value: 76.83 Mil PE Ratio: 0 PB Ratio: 2.91 GF Score: 44/100

Q3 2022 Immunovia AB (publ) Earnings Call Transcript

Nov 10, 2022 / 01:00 PM GMT
Release Date Price: kr14.69 (+0.63%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

IMMNOV.ST - Immunovia AB (publ)
Q3 2022 Immunovia AB (publ) Earnings Call
Nov 10, 2022 / 01:00PM GMT

=====================
Conference Call Participants
=====================
* >>Karin Liwendahl - CFO
* >>Philipp Mathieu - CEO
* >>Jeff Borcherding - Unit President

=====================
Presentation
--------------------------------------------------------------------------------
Operator [1]
--------------------------------------------------------------------------------

Ladies and gentlemen, welcome to the Immunovia Q3 Interim Report 2022 Conference Call. I'm [Shasa] the Chorus Call operator. I would like to remind The conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast. At this time, it is my pleasure to hand over to Karin Almqvist Liwendahl. Please go ahead.

--------------------------------------------------------------------------------
>>Karin Liwendahl - CFO, [2]
------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot